Zhu, Gui-Qi <br/><br/>
A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.  [electronic resource] 

 -  Oncotarget  Sep 2015 
 - 26757-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.5610  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alkaline Phosphatase--blood<br/>Bilirubin--blood<br/>Cholagogues and Choleretics--administration & dosage<br/>Cholangitis, Sclerosing--therapy<br/>Disease Progression<br/>Humans<br/>Liver--pathology<br/>Liver Transplantation<br/>Metronidazole--administration & dosage<br/>Middle Aged<br/>Mycophenolic Acid--administration & dosage<br/>Odds Ratio<br/>Proportional Hazards Models<br/>Randomized Controlled Trials as Topic<br/>Research Design<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Ursodeoxycholic Acid--administration & dosage<br/>Young Adult